Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer.
J Natl Compr Canc Netw. 2023 Jan;21(1):43-50.e2. doi: 10.6004/jnccn.2022.7070.
J Natl Compr Canc Netw. 2023.
PMID: 36634610
Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial.
Holzgreve A, Unterrainer M, Calais J, Adams T, Oprea-Lager DE, Goffin K, Lopci E, Unterrainer LM, Kramer KKM, Schmidt-Hegemann NS, Casuscelli J, Stief CG, Ricke J, Bartenstein P, Kunz WG, Mehrens D.
Holzgreve A, et al. Among authors: kramer kkm.
Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3750-3754. doi: 10.1007/s00259-023-06332-y. Epub 2023 Jul 10.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 37428216
Free PMC article.
Item in Clipboard
Cite
Cite